Showing results (1551-1560 of 1,631) with videos related to
Sort By:
Pageof 164
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 5, 2017
Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosisXiao-Ming Meng, Hai-Di Li, Wei-Feng Wu, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 28, 2018
Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell deathLi Gao, Ming-Ming Liu, Hong-Mei Zang, et al.Frontiers in Pharmacology|December 22, 2016
Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal InflammationLi Gao, Wei-Feng Wu, Lei Dong, et al.Journal of Pharmaceutical Analysis|July 25, 2025
Aldolase A accelerates hepatocarcinogenesis by refactoring c-Jun transcriptionXin Yang, Guang-Yuan Ma, Xiao-Qiang Li, et al.Cancer Communications (London, England)|March 20, 2024
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockadeJie Mei, Yun Cai, Rui Xu, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|July 27, 2010
[Application of Warthin-Starry stain, immunohistochemistry and transmission electron microscopy in diagnosis of cat scratch disease]Juan Huang, Lin Dai, Song Lei, et al.International Immunopharmacology|July 14, 2022
miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-βXin Chen, Sai Zhu, Si-Yu Chen, et al.Cancer Biotherapy & Radiopharmaceuticals|October 7, 2021
Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma TissuesWang-Yang Ye, Hui-Ping Lu, Jian-Di Li, et al.Discover Oncology|July 4, 2025
Molecular mechanism and biological pathway of high-expressed RAD51 in regulating cell adhesion and potentially affecting oral squamous cell carcinomaYu-Xing Tang, Yu-Yan Pang, Yan Cui, et al.World Journal of Oncology|December 19, 2024
<i>ACTR10</i> Overexpression Facilitates the Progression and Tyrosine Kinase Inhibitor Resistance in Hepatocellular CarcinomaJie Luo, Kai Qin, Rong Quan He, et al.Pageof 164